Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Ordinary Shares (represented by American Depository Shares)
-
Shares outstanding
-
72.8M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
21.3M
-
Shares change
-
+20.8M
-
Total reported value, excl. options
-
$228M
-
Value change
-
+$223M
-
Number of buys
-
29
-
Price
-
$10.70
Significant Holders of Abivax S.A. - Ordinary Shares (represented by American Depository Shares) (ABVX) as of Q4 2023
30 filings reported holding ABVX - Abivax S.A. - Ordinary Shares (represented by American Depository Shares) as of Q4 2023.
Abivax S.A. - Ordinary Shares (represented by American Depository Shares) (ABVX) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.3M shares
of 72.8M outstanding shares and own 29.21% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (4.3M shares), Blackstone Inc. (2.37M shares), Cormorant Asset Management, LP (2.13M shares), COMMODORE CAPITAL LP (1.9M shares), GREAT POINT PARTNERS LLC (1.55M shares), FRANKLIN RESOURCES INC (1.25M shares), TCG Crossover Management, LLC (1.1M shares), Nantahala Capital Management, LLC (1.01M shares), VR Adviser, LLC (999K shares), and Samsara BioCapital, LLC (850K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.